BioSpace News Archive

Renalytix AI plc, announced a collaboration with AstraZeneca to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases.

Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, has been awarded a Small Business Innovation Research Grant of $300,228 from the National Institutes of Health to study potential therapies that target fibrotic processes in the kidneys.

Rising incidence of infertility across the globe is one of the major factors driving the assisted reproductive technology (ART) market.

Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it continues to partner with European Wound Management Association (“EWMA”) to offer advanced workshops on wound care a

Brain stimulation therapy is a procedure to treat certain mental disorders.

Pulse electromagnetic field therapy (PEMF) is a non-invasive treatment which creates micro-current in a tissue.

Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products including NIPT, commends the recent guideline update from the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) recommending that all pregnant patients be offered aneuploidy screening, regardless of age or risk factors. This rec

Rigel Pharmaceuticals (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, approved by the Compensation Committee of Rigel’s Board of Directors and granted as an inducement material to an employee’s employment with Rigel, in accordance with NASDAQ Lis

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that it has regained compliance with the minimum bid price requirement for continued listing on the NASDAQ Capital Market pursuant to Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). On August 19, 2020

− Dr. Shacham Recognized for Her Contributions to Science and Inspiring Others with Her Vision, Leadership and Achievement